PT UBC Medical Indonesia Tbk (IDX:LABS)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
126.00
+3.00 (2.44%)
May 14, 2025, 1:48 PM WIB

IDX:LABS Cash Flow Statement

Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
2,9522,1902,834308.25
Depreciation & Amortization
12,3999,8929,2708,077
Other Operating Activities
-29,032-26,909-27,151-29,016
Operating Cash Flow
-13,680-14,828-15,047-20,631
Capital Expenditures
-6,809-19,405-3,280-11,710
Sale of Property, Plant & Equipment
392.84240.235,1471,316
Sale (Purchase) of Intangibles
-438.35-6,147--
Investment in Securities
-4,404-2,400-
Other Investing Activities
--713.06-4,511-
Investing Cash Flow
-6,855-21,621-5,044-10,394
Short-Term Debt Issued
2,6512,759--
Long-Term Debt Issued
-18,86318,56333,968
Total Debt Issued
2,65121,62218,56333,968
Long-Term Debt Repaid
-11,336-547.47-44,647-303.61
Net Debt Issued (Repaid)
-8,68521,075-26,08533,665
Issuance of Common Stock
71,40018,16335,405-
Other Financing Activities
-3,243---
Financing Cash Flow
59,47239,2389,32033,665
Net Cash Flow
38,9372,789-10,7702,640
Free Cash Flow
-20,490-34,233-18,327-32,341
Free Cash Flow Margin
-13.88%-25.04%-19.65%-24.88%
Free Cash Flow Per Share
-5.19-14.54--
Cash Interest Paid
3,0412,1531,554112.31
Cash Income Tax Paid
9,7777,0664,4858,419
Levered Free Cash Flow
-41,257-34,775-22,351-
Unlevered Free Cash Flow
-39,357-33,430-21,380-
Change in Net Working Capital
50,10321,42229,493-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.